Graham M. O’Hanlon

Author

Graham M. O’Hanlon

Also Known As

G M O'Hanlon, G M OʼHanlon, G. M. O'HANLON, G. M. O'Hanlon, G.M. O'Hanlon, GRAHAM M. O'HANLON, Graham M O'Hanlon, Graham M. O'Hanlon, Graham M. O’Hanlon, Graham O'Hanlon

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Southern General Hospital Institute of Neurological Sciences Leiden University Medical Center University of Glasgow Leiden University

About

Graham M. O’Hanlon is an author at Southern General Hospital specializing in medicine, neurology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	705
2	Social Sciences	3	3	239
3	Allergy	2	2	283
4	Biochemistry	1	1	31
5	Biology	1	1	14

Graham M. O’Hanlon

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations Carl S. Goodyear, Graham M. O’Hanlon, Jaap J. Plomp, Journal of Clinical Investigation ImmunologyPathologySocial SciencesCampylobacter Jejuni LipopolysaccharidesNeuroinflammation	1999	210
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates Jaap J. Plomp, Peter Molenaar, Graham M. O’Hanlon, Annals of Neurology	1999	194
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal Graham M. O’Hanlon Brain Immunocytochemical TechniqueImmunologyPeripheral NerveImmunotherapyComplement-dependent Destruction	2001	190
Complex Gangliosides at the Neuromuscular Junction Are Membrane Receptors for Autoantibodies and Botulinum Neurotoxin But Redundant for Normal Synaptic Function Roland Bullens, Graham M. O’Hanlon, Eric R. Wagner, Journal of Neuroscience	2002	106
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. Hugh J. Willison, Graham M. O’Hanlon, G Paterson, Journal of Clinical Investigation ImmunologyPathologyDisease Gene IdentificationImmunogeneticsExperimental Neuropathology	1996	93
Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury Graham M. O’Hanlon Brain	2003	86
Anti‐disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions Susan K. Halstead, Ian Morrison, Graham M. O’Hanlon, Glia	2005	61
Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies Graham M. O’Hanlon, Gary J. Paterson, Jennifer A. Veitch, Acta Neuropathologica Peripheral NervesAutoimmune DiseaseMedicineImmunologyAntigen Processing	1998	58
Peripheral Neuropathy Associated with Anti-GM2 Ganglioside Antibodies: Clinical and Immunopathological Studies Graham M. O’Hanlon, Jean Veitch, Eduard Gallardo, Autoimmunity Peripheral Neuropathy AssociatedNeurological DisorderImmunologyNeuropathic PainPathology	2000	57
Anti-GM1 Ganglioside Antibodies Cloned from Autoimmune Neuropathy Patients Show Diverse Binding Patterns in the Rodent Nervous System Graham M. O’Hanlon, Gary J. Paterson, G Wilson, Journal of Neuropathology & Experimental Neurology	1996	47

Page 1